A detailed history of Strs Ohio transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Strs Ohio holds 17,900 shares of CMPX stock, worth $24,523. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,900
Previous 17,900 -0.0%
Holding current value
$24,523
Previous $17,000 88.24%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$1.2 - $2.29 $1,320 - $2,519
-1,100 Reduced 5.79%
17,900 $35,000
Q2 2023

Jul 31, 2023

BUY
$2.64 - $3.48 $50,160 - $66,120
19,000 New
19,000 $60,000

Others Institutions Holding CMPX

About Compass Therapeutics, Inc.


  • Ticker CMPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 101,285,000
  • Market Cap $139M
  • Description
  • Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...
More about CMPX
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.